Skip to main content
Terug
Watch Compare

bioAffinity Technologies, Inc.

Datakwaliteit: 100%
Ook genoteerd als BIAFW Nasdaq
BIAF
Nasdaq Services Engineering & Management Services
€ 3,35
▲ € 0,03 (0,90%)
Marktkapitalisatie: 14,94 M
Prijs
€ 3,32
Marktkapitalisatie
14,94 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,01 — conservative balance sheet
Negative free cash flow of -9,39 M
Capital efficient — spends only 0,98% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-34,18%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-440,72%
Onder sectorgemiddelde (-15,95%)
ROIC-142,32%
Net Margin-241,96%
Op. Margin-171,58%

Veiligheid

Debt / Equity
0,01
Onder sectorgemiddelde (0,39)
Current Ratio3,65
Interest Coverage-238,27

Waardering

PE (TTM)
-1,00
Boven sectorgemiddelde (-1,17)
P/B Ratio1,68
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -1,0 -1,2
P/B 1,7 1,4
ROE % -440,7 -16,0
Net Margin % -242,0 -18,3
Rev Growth 5Y % — 4,2
D/E 0,0 0,4

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q32025 -€ 2,70 -€ 4,74 -75,6%
Q22025 -€ 3,00 -€ 5,10 -70,0%
Q12025 -€ 4,80 -€ 4,80 0,0%
Q42024 -€ 4,20 -€ 6,30 -50,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) -34,18% Revenue Growth (3Y) -11,68%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 6,16 M Net Income (TTM) -14,91 M
ROE -440,72% ROA -182,97%
Gross Margin N/A Operating Margin -171,58%
Net Margin -241,96% Free Cash Flow (TTM) -9,39 M
ROIC -142,32% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,01 Current Ratio 3,65
Interest Coverage -238,27 Asset Turnover 0,76
Working Capital 6,25 M Tangible Book Value 6,77 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,00 Forward P/E N/A
P/B Ratio 1,68 P/S Ratio 2,42
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -62,86%
Market Cap 14,94 M Enterprise Value 7,39 M
Per Share
EPS (Diluted TTM) -8,66 Revenue / Share 1,37
FCF / Share -2,09 OCF / Share -2,07
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,98% FCF Conversion 62,97%
SBC-Adj. FCF -10,18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 6,16 M 9,36 M 7,90 M 4.803,0
Net Income -14,91 M -9,04 M -7,94 M -8,15 M
EPS (Diluted) -8,66 -0,75 -0,91 —
Gross Profit — — — 4.336,0
Operating Income -10,57 M -8,95 M -7,97 M -4,01 M
EBITDA — — — —
R&D Expenses 1,38 M 1,46 M 1,47 M 1,14 M
SG&A Expenses 9,91 M 9,94 M 6,79 M 2,73 M
D&A 504.836,0 605.637,0 249.592,0 10.182,0
Interest Expense 44.372,0 92.475,0 37.125,0 2,53 M
Income Tax 44.042,0 11.650,0 20.993,0 2.459,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 10,96 M 6,51 M 8,22 M 12,18 M
Total Liabilities 3,68 M 3,91 M 3,37 M 1,14 M
Shareholders' Equity 7,28 M 2,60 M 4,86 M 11,04 M
Total Debt 127.500,0 — — —
Cash & Equivalents 6,45 M 1,11 M 2,82 M 11,41 M
Current Assets 7,57 M 2,70 M 3,97 M 11,96 M
Current Liabilities 2,91 M 3,10 M 2,25 M 1,14 M